CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders
NCT01431235, Not applicable, Completed, Arkin
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | CBT for Patients With Attention Deficit Hyperactivity Disorder (ADHD) and Substance Use Disorders | ClinicalTrials.gov |
| NCT number | NCT01431235 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 184 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Arkin | ClinicalTrials.gov |
| Conditions | Attention Deficit Hyperactivity Disorder, Substance Use Disorders | ClinicalTrials.gov |
| Interventions | cognitive behavioral therapy for treating ADHD symptoms | ClinicalTrials.gov |
| First posted | 2011-09-09 | ClinicalTrials.gov |
| Last updated | 2017-01-16 | ClinicalTrials.gov |
Registered outcomes 10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | self reported ADHD symptoms | 6 months | Dutch self report list of ADHD symptoms by Kooij and Buitelaar | ClinicalTrials.gov |
| Secondary | Time Line Follow Back method | 6 months | self-reported alcohol and drug use | ClinicalTrials.gov |
| Secondary | Beck depression inventory | 6 months | self reported depression symptoms | ClinicalTrials.gov |
| Secondary | Beck Anxiety Inventory | 6 months | Self reported anxiety symptoms | ClinicalTrials.gov |
| Secondary | EQ-5 | 6 months | Self reported quality of living | ClinicalTrials.gov |
| Secondary | TIC-P | 6 months | health care consumption and production loss in relation to mental health problems | ClinicalTrials.gov |
| Secondary | Stroop task | 6 months | neuropsychological measure | ClinicalTrials.gov |
| Secondary | Tower of London task | 6 months | neuropsychological task | ClinicalTrials.gov |
| Secondary | BART task | 6 months | neuropsychological task on risk taking behavior | ClinicalTrials.gov |
| Secondary | urine checks | 6 months | urine checks on drug use | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 5
The papers the trial lists on ClinicalTrials.gov.
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Tower Planning | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)